The ideal test for patients with a positive ANA test or anyone concerned they may have Lupus (SLE) or a related condition.

AVISE® CTD is an advanced Connective Tissue Disease (CTD) diagnostic test leveraging the highest quality standards and scientific analysis to aid in the diagnosis of autoimmune disorders such as: Lupus (SLE), Rheumatoid Arthritis and Sjögren's syndrome among other conditions.

AVISE® CTD has demonstrated superior performance over traditional Lupus (SLE) biomarkers alone with:

  • 48% increase in sensitivity compared to ds-DNA
  • 22% increase in sensitivity compared to low C3 or C4
  • 33% increase in specificity compared to ANA

AVISE® CTD contains the following tests:

 

AVISE CTD includes Lupus SLE associated biomarkers including an AVISE Index Score, ENA markers to help distinguish specific CTD, RA panel to help rule in rheumatoid arthritis, APS panel to assess risk for thrombosis and cardiovascular events and Thyroid panel to aid in the diagnosis of Graves' and Hashimoto's Syndrome.

 

When to Use AVISE® CTD

Consider testing with AVISE® CTD for any patient with:

  • Clinical suspicion of Lupus (SLE)
  • Positive ANA test and clinical suspicion of an autoimmune rheumatic disorder
  • Positive ANA test and clinical suspicion of Connective Tissue Disease (CTD)
  • Fibromyalgia with positive ANA or suspicion of Lupus (SLE)

*To learn more about the clinical utility of AVISE® CTD from your peers or read current scientific publications, please visit our Resources library.

Request more information on the AVISE® CTD diagnostic test

Pin It on Pinterest

Share This